About Minerva Imaging

Minerva Imaging is an integrated CRO and CDMO specialized in targeted radionuclide therapies. The company focusses on the use of advanced models within oncology, cardiovascular diseases and in vivo molecular imaging for translational research and drug development. Minerva Imaging engages with its clients to understand their scientific questions and discuss how its methods and capabilities can provide answers. The facility located in Denmark offers best–in–industry fully integrated radiopharmaceutical research, drug development and manufacturing services.

Our competences build on more than two decades of research within oncology and molecular imaging performed at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark.

Contact us.

Senior Management

Carsten H. Nielsen, PhD

Co-founder, CEO

Max Damborg, MSc


Gitte Hansen, MSc


Lene Jessen, PhD


Department Managers

Moritz Braig, PhD

Digital Solutions & Technology

Pablo Moreno, MSc

Head of QA, CDMO

Philip Graasbøl Juul Pedersen, PhD

Large Animal Pharmacology & Translational Model Development

Trine Bjørnbo Engel, PhD

Small Animal Pharmacology & Molecular Oncology

Helle Jane Jacobsen, PhD

Small animal pharmacology & oncology models

Lotte Kellemann Kristensen, PhD

Nuclear Imaging

Board of Directors

Andreas Kjaer, Prof., MD, PhD, DMSc

Chairman, Co-founder

Carsten H. Nielsen, PhD

Member, Co-founder

Ricki Boye, Attorney at Law, Partner, BACH Law


Jacob Jacobsen, MSc


Join us

We are continuously looking for motivated and skilled people. Click here to see our current open positions.